2024-09-07 - Analysis Report
## CVS Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management services, and health care services.

**Performance Analysis:**

1. **Performance Relative to S&P 500:** CVS has significantly underperformed the S&P 500 (VOO) over the period analyzed. The cumulative return of CVS is -19.26%, while the S&P 500 has returned 84.86%. This results in a substantial underperformance of -107.03% compared to the benchmark.

2. **Recent Price Movements:** The current closing price of CVS is $59.3. The stock price is above its 5-day moving average ($57.63), 20-day moving average ($57.59), and 60-day moving average ($58.85). This suggests a potential short-term upward momentum.

3. **Technical Indicators:**

    * **RSI:** The RSI of 68.01 indicates that CVS is currently in the overbought territory. This suggests that the stock might be due for a correction in the near term.
    * **PPO:** The PPO of 0.18 suggests that the stock is experiencing a bullish divergence.
    * **Relative Divergence:** The recent (20-day) relative divergence is -11.1, indicating a potential short-term decline.
    * **Expected Return:** The expected return of 12.6% represents the maximum potential return over the next 5 years, based on the current investment amount.

4. **Recent Earnings Performance and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

CVS has consistently exceeded earnings expectations in recent quarters. The most recent earnings report, for the quarter ending August 7, 2024, showed EPS of $1.83, exceeding the expected EPS of $1.73. This suggests a healthy growth trajectory for the company.

**Summary:**

CVS has significantly underperformed the S&P 500 in the past, exhibiting a -107.03% underperformance compared to the benchmark. However, recent price movements indicate potential short-term upward momentum. Technical indicators suggest a mix of bullish and bearish signals, with a potential for near-term correction. Despite overbought conditions, CVS has consistently exceeded earnings expectations in recent quarters, indicating a healthy growth trajectory. The expected return of 12.6% represents a potential for attractive long-term growth. 
